The global Kinesin Like Protein Kif11 market is expanding as pharmaceutical companies, research institutions, and hospitals invest in advanced molecular targets to support cancer research, drug discovery, and targeted therapy development. The market was valued at USD 450 million in 2023 and is projected to reach USD 980 million by 2032, growing at a CAGR of 9.1%. The Kinesin Like Protein Kif11...